Bridgewater Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Bridgewater Advisors's ELV Position: Q2 2026 in Review
Bridgewater Advisors increased its Elevance Health (ELV) stake by 12% in Q2 2026, buying an estimated $23K and bringing the position to 590 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #447.
Bridgewater Advisors first reported a position in ELV in Q1 2025 and has held it in 5 quarters since. The position peaked at $237K in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Bridgewater Advisors held 590 shares of Elevance Health worth $221K as of Q2 2026.
- Bridgewater Advisors bought 62 Elevance Health shares in Q2 2026, an estimated $23K.
- Elevance Health made up 0.01% of Bridgewater Advisors's portfolio in Q2 2026, its #447 holding.
- Bridgewater Advisors first reported a position in Elevance Health in Q1 2025 and has held it in 5 quarters since.
- Bridgewater Advisors's Elevance Health position peaked at $237K in Q1 2025.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.